Beeran Meghpara is an Ophthalmology physician affiliated with Wills Eye Hospital. OpenAlex indexes 24 publications with 351 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
840 Walnut St Ste 920
Philadelphia, PA 191075109
Telephone
215-928-3180Registry record last updated 9 Apr 2018.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year202548 payments$69,477openpaymentsdata.cms.gov ↗
- Johnson & Johnson Surgical Vision, Inc.Program year202529 payments$33,781openpaymentsdata.cms.gov ↗
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year202529 payments$33,045openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
64.6%Corticosteroid36.5%Prednisolone Acetate75%Fluorometholone16%Flarex9%Part D≥163 patientsQuinolone Antimicrobial8.4%Ofloxacin100%Part D≥86 patients+ 6 more classes in this area
Anti-infectives
24.5%Macrolide12.3%Erythromycin100%Part D≥69 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor8.9%Valacyclovir100%Part D≥41 patients+ 1 more class in this area
Cardiovascular
2.9%Beta blocker2.9%Timolol Maleate100%Part D≥19 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Development of the U.S. Academic Ophthalmology Faculty Database (US-AOFD): A Cross-Sectional Descriptive Analysis
Journal of Academic Ophthalmology
2026 - Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study
JAMA Ophthalmology
2025 - P439: TACSTD2-related gelatinous drop-like corneal dystrophy: An asymmetrical exception
Genetics in Medicine Open
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Teresa Horan, MD
Wills Eye Hospital
Julia Haller, MD
Wills Eye Hospital
Allen Ho, MD
Wills Eye Hospital
Ralph Eagle, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”